SOUTHWEST ONCOLOGY GROUP

西南肿瘤集团

• 批准号: 3556193
• 负责人: THOMAS Patrick MILLER
• 金额: $ 22.03万
• 依托单位: UNIVERSITY OF ARIZONA
• 依托单位国家: 美国
• 财政年份: 1978
• 资助国家: 美国
• 起止时间: 1978-01-01 至 1992-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/3556193
• 关键词: Hodgkin's disease; Mycobacterium bovis; adult human (21+); bladder neoplasm; bleomycin; breast neoplasms; carmustine; cis platinum compound; combination cancer therapy; cooperative study; cyclophosphamide; doxorubicin; drug metabolism; drug screening /evaluation; fluorouracil; head /neck neoplasm; human subject; human therapy evaluation; imaging /visualization /scanning; leukemia; lung neoplasms; lymphoma; melanoma; melphalan; metastasis; monoclonal antibody; multiple myeloma; neoplasm /cancer chemotherapy; neoplasm /cancer immunotherapy; neoplasm /cancer radiation therapy; neoplasm /cancer radionuclide diagnosis; neoplasm /cancer surgery; neoplasm /cancer thermotherapy; ovary neoplasms; pediatric neoplasm /cancer; prednisone; radiotracer; sarcoma; skin neoplasms; stromal cells; testis neoplasms; vincristine

This grant application requests funding to continue support for investigators at the Arizona Cancer Center to improve cancer treatment for humans by participation in the Southwest Oncology Group. Specific aims include: 1. To develop scientific leads using the laboratories and clinics of the Arizona Cancer Center (University of Arizona) worthy of testing in a national cooperative group (Southwest Oncology Group). 2. To incorporate these pilot experiences into large confirmatory or randomized multi-institution trials. 3. To increase participation in Southwest Oncology Group trials by entering a larger number of patients on studies. 4. To continue and expand our already large commitment to scientific leadership of the Southwest Oncology Group. 5. To make available state-of-the-art treatment to a large proportion of patients throughout the State of Arizona by increasing the number of community clinical research satellites interested in participating in Southwest Oncology Group studies.

该赠款申请要求资金继续支持 亚利桑那州癌症中心的研究人员， 通过参与西南肿瘤学为人类提供治疗 组 具体目标包括： 1. 利用以下机构的实验室和诊所开发科学线索： 亚利桑那州癌症中心（亚利桑那大学）值得 在国家合作组（西南肿瘤学 组）。 2. 将这些试点经验纳入大型验证性 或随机多机构试验。 3. 增加西南肿瘤组试验的参与 通过让更多的患者参与研究 4. 继续并扩大我们已经作出的巨大承诺， 西南肿瘤组的科学领导。 5. 为了给一个大的 亚利桑那州的患者比例， 增加社区临床研究卫星的数量 有兴趣参加西南肿瘤学小组的研究。